GSK-4336A

GSK-4336A
Legal status
Legal status	US: Investigational new drug;
Identifiers
	IUPAC name 7,9-dichloro-3-oxo-N-[4-(trifluoromethyl)phenyl]-4,5-dihydro-1,4-benzoxazepine-5-carboxamide;
CAS Number	1067226-47-4 ;
PubChem CID	71054853;
ChemSpider	129265394;
ChEMBL	ChEMBL5203846;
Chemical and physical data
Formula	C17H11Cl2F3N2O3
Molar mass	419.18 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1C(=O)NC(C2=C(O1)C(=CC(=C2)Cl)Cl)C(=O)NC3=CC=C(C=C3)C(F)(F)F;
	InChI InChI=1S/C17H11Cl2F3N2O3/c18-9-5-11-14(24-13(25)7-27-15(11)12(19)6-9)16(26)23-10-3-1-8(2-4-10)17(20,21)22/h1-6,14H,7H2,(H,23,26)(H,24,25); Key:USVVDHAIRZSKRE-UHFFFAOYSA-N;

GSK4336A is a drug which acts as a selective androgen receptor modulator (SARM), and was developed for androgen replacement therapy.^[1]^[2]

References

Legal status

Legal status	US: Investigational new drug
Identifiers
IUPAC name 7,9-dichloro-3-oxo-N-[4-(trifluoromethyl)phenyl]-4,5-dihydro-1,4-benzoxazepine-5-carboxamide
CAS Number	1067226-47-4^Y
PubChem CID	71054853
ChemSpider	129265394
ChEMBL	ChEMBL5203846
Chemical and physical data
Formula	C₁₇H₁₁Cl₂F₃N₂O₃
Molar mass	419.18 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES C1C(=O)NC(C2=C(O1)C(=CC(=C2)Cl)Cl)C(=O)NC3=CC=C(C=C3)C(F)(F)F
InChI InChI=1S/C17H11Cl2F3N2O3/c18-9-5-11-14(24-13(25)7-27-15(11)12(19)6-9)16(26)23-10-3-1-8(2-4-10)17(20,21)22/h1-6,14H,7H2,(H,23,26)(H,24,25) Key:USVVDHAIRZSKRE-UHFFFAOYSA-N